ClinicalTrials.gg
Not yet recruitingNCT07848087Updated Nov 10, 2026

The Effects of a Respiratory Assistive Device Health Education Manual on Readmission Rates and Self-Care Efficacy: A Randomized Controlled Trial

An interventional study of Structured Discharge Educational Manual for Respiratory Assistive Devices and Routine Discharge Planning Service in Discharge Planning for Patients Requiring Respiratory Assistive Devices, sponsored by Fu Jen Catholic University Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Fu Jen Catholic University Hospital · Not applicable, Interventional, and Health services research

How we know

Updated Nov 10, 2026Start date movedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates whether adding an easy-to-read, illustrated education booklet to routine discharge planning helps patients and their family caregivers safely use home respiratory equipment.

Patients who need breathing devices after leaving the hospital often face challenges managing equipment and recognizing warning symptoms, which can lead to complications or hospital readmissions. Participants in this study are randomly assigned (by chance) to one of two groups: one group receives standard hospital discharge instructions, while the other group receives the standard instructions along with a specialized, step-by-step respiratory care booklet. Researchers will assess how prepared patients feel to return home the day before discharge, and will follow up by phone one week later to check on device use, daily care confidence, and any unexpected doctor or emergency room visits.

02

Conditions studied

  • Discharge Planning for Patients Requiring Respiratory Assistive Devices

Keywords

  • Respiratory Assistive Devices, Health Education Manual, Readmission Rate, Readiness for Hospital Discharge.
03

In context

Lead sponsor

Fu Jen Catholic University Hospital is the lead sponsor of 33 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hospitalized patients enrolled in the discharge planning service of Fu Jen Catholic University Hospital who are evaluated as requiring referral to respiratory assistive devices, long-term care services, or home respiratory care facilities/resources.
  • Evaluated and confirmed by the hospital healthcare team as in need of discharge planning services specifically related to respiratory assistive devices.
  • Aged 18 years or older.
  • Able to comprehend the study purpose and provide written (if the patient is unable to communicate or express consent, a primary caregiver may provide consent and complete responses on their behalf).

Exclusion criteria

Exclusion Criteria:

  • Patients receiving palliative or hospice care with an anticipated of less than 1 month.
  • Patients with altered consciousness or dementia who do not have an eligible primary caregiver available to receive education and participate on their behalf.
  • Severe visual impairment or inability to comprehend Chinese text and pictorial materials.
  • Refusal to sign the written form despite meeting the inclusion criteria.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Receives routine discharge planning supplemented with the structured respiratory assistive device health education manual.

    Behavioral: Structured Discharge Educational Manual for Respiratory Assistive Devices

  • Active comparator
    Control Group

    Receives routine discharge planning services, including standard oral education and device instructions.

    Other: Routine Discharge Planning Service

Interventions

  • BehavioralStructured Discharge Educational Manual for Respiratory Assistive Devices

    In addition to routine discharge planning, participants receive a structured, pictorial educational manual developed by the Division of Thoracic Medicine at Fu Jen Catholic University Hospital. The manual comprises four structured modules: 1. Patient triage for home mechanical ventilation, discharge planning workflow, respiratory assistive devices introduction, and operational precautions; 2. Verification of eligibility and application procedures for medical assistive device subsidies provided by the New Taipei City Department of Health; 3. Relevant information and documentation preparation for home respiratory care institutions for ventilator-dependent cases; and 4. Long-term Care 2.0 application procedures and service introduction for eligible participants.

    Also known as: Pictorial Discharge Planning Manual for Home Respiratory Care

  • OtherRoutine Discharge Planning Service

    Participants receive conventional hospital discharge planning care delivered by a discharge planning respiratory therapist. This includes verbal education, individual patient care need assessment, and standard operational guidance on prescribed respiratory assistive devices.

    Also known as: Standard Discharge Care

06

What researchers measure

Primary outcomes

  1. Readiness for Hospital Discharge Scale (RHDS) Score

    Assessed using the Chinese version of the Readiness for Hospital Discharge Scale (RHDS). The scale consists of 23 items across four dimensions: personal status, knowledge, coping ability, and expected support. Item 1 is a dichotomous question ("Yes/No") regarding readiness for discharge, while the remaining 22 items are rated on an 11-point numeric scale ranging from 0 to 10 (with Items 3 and 6 reverse-scored). Higher total scores indicate a higher level of readiness for hospital discharge.

    Time frame: 1 day prior to hospital discharge

Secondary outcomes

  1. Home Readiness Score for Respiratory Assistive Devices

    Measured using the Home Readiness Questionnaire for Respiratory Assistive Devices developed by the research team. It assesses 11 items covering three domains: equipment and service satisfaction, device knowledge and operation, and alarm management/emergency handling. Items are scored on a 5-point Likert scale (1 = very dissatisfied/unable to perform to 5 = very satisfied/independent). The final score is calculated as a percentage: 70-100% indicates excellent readiness, 40-69% indicates adequate readiness, and 0-39% indicates high risk requiring re-education.

    Time frame: 1 week after hospital discharge

  2. Assistive Technology Satisfaction Score (T-QUEST 2.0)

    Evaluated using the Taiwanese version of the Quebec User Evaluation of Satisfaction with Assistive Technology (T-QUEST 2.0). The scale includes 8 items assessing satisfaction with the assistive device itself and 5 items evaluating satisfaction with related services, providing a comprehensive assessment of patient satisfaction with home respiratory assistive technology.

    Time frame: 1 week after hospital discharge

  3. Utilization Rate of Respiratory Assistive Devices

    The proportion (percentage) of participants who consistently use the prescribed home respiratory assistive devices (e.g., oxygen therapy, nebulizers, suction units, or non-invasive ventilators) as instructed, assessed via telephone follow-up.

    Time frame: 1 week after hospital discharge

  4. Hospital Readmission Rate

    The percentage of participants who experience an unplanned all-cause hospital readmission following index discharge.

    Time frame: At 7 days and 30 days post-discharge

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Morton K, Sanderson E, Dixon P, King A, Jenkins S, MacNeill SJ, Shaw A, Metcalfe C, Chalder M, Hollingworth W, Benger J, Calvert J, Purdy S. Care bundles to reduce re-admissions for patients with chronic obstructive pulmonary disease: a mixed-methods study. Southampton (UK): NIHR Journals Library; 2019 Jun. Available from http://www.ncbi.nlm.nih.gov/books/NBK541984/ PubMed 31194314 ↗
  • Ducic Y. Intraoperative Free Flap Monitoring Using Indocyanine Green. JAMA Facial Plast Surg. 2015 Nov-Dec;17(6):427. doi: 10.1001/jamafacial.2015.1060. No abstract available. PubMed 26335198 ↗
  • Klein DJ. Vector representations of kekule structures of benzenoids. Acta Chim Slov. 2010 Sep;57(3):591-6. PubMed 24061805 ↗
  • Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, Bennett DA. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep;74(3):478-89. doi: 10.1002/ana.23964. Epub 2013 Jul 10. PubMed 23798485 ↗
  • Bajorek SA, McElroy V. Discharge Planning and Transitions of Care. AHRQ Patient Safety Network. March 25, 2020.
  • Flaster R. Four strategies cut newborn readmissions. Contemporary Pediatrics. 2017;34(7):10.
  • Hong LP, Tseng MC. A survey on satisfaction and utilization of assistive mobility technology: A case study of borrowers in Kaohsiung Special Education Resource Center. Educational Studies. 2015;(34):121-183.
  • Chang MC, Jeng YC, Leu GY, Chang SC. Suitability assessment of printed health education materials for pediatric care. Tzu Chi Nursing Journal. 2015;14(4):58-68.
  • Lin YH, Kao CC, Huang AM, Chi MT, Chou FH. [Psychometric testing of the chinese version of the readiness for hospital discharge scale]. Hu Li Za Zhi. 2014 Aug;61(4):56-65. doi: 10.6224/JN.61.4.56. Chinese. PubMed 25116315 ↗
  • National Development Council. Population Projections for the R.O.C. (Taiwan): 2022-2070. National Development Council; 2022.
  • Ministry of the Interior, Department of Household Registration. Demographic statistics analysis for December 2025. Ministry of the Interior Global Information Website; 2026.
  • Wilkinson T. Understanding disease mechanisms at the nanoscale: endothelial apoptosis and microparticles in COPD. Thorax. 2016 Dec;71(12):1078-1079. doi: 10.1136/thoraxjnl-2016-208993. Epub 2016 Sep 26. No abstract available. PubMed 27672115 ↗
  • Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003 Feb 4;138(3):161-7. doi: 10.7326/0003-4819-138-3-200302040-00007. PubMed 12558354 ↗
  • Gemelli N, Las Heras M, San Roman E. Barium Aspiration After Esophagography. Arch Bronconeumol (Engl Ed). 2020 Feb 13:S0300-2896(20)30027-2. doi: 10.1016/j.arbres.2019.12.036. Online ahead of print. No abstract available. English, Spanish. PubMed 32063391 ↗
  • Ho CCY, Ng MSN, Choi KC, Chan CWH. Effect of pictorial action plan on self-management in older patients with chronic obstructive pulmonary disease: Randomised controlled trial. Geriatr Nurs. 2025 May-Jun;63:231-237. doi: 10.1016/j.gerinurse.2025.03.044. Epub 2025 Apr 9. PubMed 40209600 ↗
  • Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan AM, Carlin B, Drummond MB, Ekstrom M, Garvey C, Graney BA, Jackson B, Kallstrom T, Knight SL, Lindell K, Prieto-Centurion V, Renzoni EA, Ryerson CJ, Schneidman A, Swigris J, Upson D, Holland AE. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 Nov 15;202(10):e121-e141. doi: 10.1164/rccm.202009-3608ST. PubMed 33185464 ↗
  • Oh EG, Lee HJ, Yang YL, Kim YM. Effectiveness of Discharge Education With the Teach-Back Method on 30-Day Readmission: A Systematic Review. J Patient Saf. 2021 Jun 1;17(4):305-310. doi: 10.1097/PTS.0000000000000596. PubMed 30882616 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Nov 2026; primary completion for Jul 2027, 8 months later.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, on Nov 10, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartEst.
Nov 9, 2026was Sep 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 15, 2026→Nov 9, 2026
Nov 10, 2026
Registered
First appeared on the registry
Sep 29, 2026
Show all 2 updates
  1. Nov 10, 2026
    Start date Sep 15, 2026→Nov 9, 2026
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07848087
Lead sponsor
Fu Jen Catholic University Hospital
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Nov 9, 2026 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

CHUN YING HUANG, B.S., RT
Contact
c03635@mail.fjuh.fju.edu.tw
+886-85128888 ext. #23423

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion